Provided by Tiger Trade Technology Pte. Ltd.

United Therapeutics

524.28
-2.7200-0.52%
Pre-market: 524.280.00000.00%08:51 EDT
Volume:796.63K
Turnover:417.78M
Market Cap:22.98B
PE:18.82
High:529.94
Open:522.58
Low:520.00
Close:527.00
52wk High:548.12
52wk Low:266.98
Shares:43.83M
Float Shares:41.99M
Volume Ratio:1.73
T/O Rate:1.90%
Dividend:- -
Dividend Rate:- -
EPS(TTM):27.86
EPS(LYR):27.86
ROE:19.71%
ROA:12.42%
PB:3.24
PE(LYR):18.82

Loading ...

United Therapeutics appoints new director, updates bylaws

TIPRANKS
·
Jan 23

United Therapeutics Appoints Kevin J. Tracey to Board of Directors

Reuters
·
Jan 22

United Therapeutics Corporation Announces Appointment of Kevin J. Tracey to Its Board of Directors

THOMSON REUTERS
·
Jan 22

United Therapeutics Director Jan Malcolm Reports Disposal of Common Shares

Reuters
·
Jan 21

The Bull Case For United Therapeutics (UTHR) Could Change Following Phase 3 Ralinepag Trial Completion - Learn Why

Simply Wall St.
·
Jan 18

Assessing United Therapeutics (UTHR) Valuation After Recent Share Price Pullback

Simply Wall St.
·
Jan 17

United Therapeutics EVP & General Counsel Paul Mahon Reports Disposal of Common Shares

Reuters
·
Jan 16

Leerink Partners Reaffirms Their Buy Rating on United Therapeutics (UTHR)

TIPRANKS
·
Jan 14

United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares

Reuters
·
Jan 14

United Therapeutics’ Phase 3 Ralinepag Trial Reaches Completion, Setting Up a Key Catalyst in Pulmonary Arterial Hypertension

TIPRANKS
·
Jan 13

United Therapeutics President and COO Michael Benkowitz Reports Disposal of Common Shares

Reuters
·
Jan 08

United Therapeutics Corp : Leerink Partners Raises Target Price to $565 From $517

THOMSON REUTERS
·
Jan 07

United Therapeutics Director Jan Malcolm Reports Disposal of Common Shares

Reuters
·
Jan 07

United Therapeutics Is Maintained at Buy by UBS

Dow Jones
·
Jan 07

UBS Adjusts Price Target on United Therapeutics to $645 From $600, Maintains Buy Rating

MT Newswires Live
·
Jan 06

United Therapeutics Director Christopher Causey Reports Sale of Common Shares

Reuters
·
Jan 06

United Therapeutics CEO to Present Company Update at J.P. Morgan Healthcare Conference

Reuters
·
Jan 05

United Therapeutics EVP & General Counsel Paul A. Mahon Reports Disposal of Common Shares

Reuters
·
Jan 03

United Therapeutics EVP & General Counsel Paul A. Mahon Reports Disposal of Common Shares

Reuters
·
Dec 30, 2025

S&P 500 Futures Flat In Premarket Trading; United Therapeutics, Intel Lag

Dow Jones
·
Dec 24, 2025